C19orf12

Across TCGA pan-cancer cohorts, C19orf12 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated C19orf12 data layer compared with 27 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher C19orf12 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated C19orf12 expression acts as an unfavorable survival marker.

ESCA, LUAD, and COAD are the cancer types where C19orf12 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.130	0.687	<.001	12	view →
LUAD	OS	Median	All	0.258	0.787	.018	6	view →
COAD	DFS	Median	II,III,IV	0.073	0.744	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

C19orf12–ESCA (OS)

Open the ESCA breakdown →